Back to today’s briefing

Story perspectives

New Blood Tests Revolutionize Colorectal Cancer Screenings at 45

4/18/2025

25 4

Summary

Story summary

The American Cancer Society recommends that individuals at average risk start colorectal cancer screenings at 45. Innovative blood tests, such as Guardant Health's Shield, offer high accuracy in detecting cancer. While Medicare covers these tests, private insurance may not. Exciting research is underway, including a portable screening device from the University of Texas at El Paso.

1 of 1

Story summary

The American Cancer Society recommends that individuals at average risk start colorectal cancer screenings at 45. Innovative blood tests, such as Guardant Health's Shield, offer high accuracy in detecting cancer. While Medicare covers these tests, private insurance may not. Exciting research is underway, including a portable screening device from the University of Texas at El Paso.